Nuvectis Pharma, Inc. insider trading
NVCT$21.92+1.20 (+5.79%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+261.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flowKey players
- RBRon Bentsur11.3206%
- MCMarlio Charles Mosseri10.1158%
- EPEnrique Poradosu5.544%
- SSShay Shemesh5.5033%
- MJMichael J. Carson0.7063%
- KHKenneth Hoberman0.5161%
- MLMatthew L. Kaplan0.4903%
- JFJames F. Oliviero III0.377%
- JSJuan Sanchez0.3493%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| NVCT | Marlio Charles Mosseri | Open market purchase$916K | +1.5% | $18.32 | $916K | Jun 30, 2026 | Jul 1, 2026 |
| NVCT | Ron Bentsur | Open market purchase$250K | +0.3% | $20.00 | $250K | Jun 30, 2026 | Jul 1, 2026 |
| NVCT | Ron Bentsur | Open market purchase$28.6K | +0.1% | $5.72 | $28.6K | Nov 5, 2025 | Nov 6, 2025 |
| NVCT | Juan Sanchez | Open market purchase$75.3K | +19.8% | $5.79 | $75.3K | Nov 5, 2025 | Nov 6, 2025 |
| NVCT | Matthew L. Kaplan | Open market purchase$64.2K | +9.7% | $5.84 | $64.2K | Nov 5, 2025 | Nov 6, 2025 |
| NVCT | Marlio Charles Mosseri | Open market purchase$457K | +2.3% | $6.28 | $457K | Oct 27, 2025 | Oct 29, 2025 |
| NVCT | Marlio Charles Mosseri | Open market purchase$215K | +1.1% | $6.15 | $215K | Oct 24, 2025 | Oct 29, 2025 |
| NVCT | Marlio Charles Mosseri | Open market purchase$284K | +1.5% | $6.06 | $284K | Oct 23, 2025 | Oct 29, 2025 |